CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,157 enrolled
Drug / intervention
Micamlodrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01353274
NCT01353274N/ACompleted
CompareCT.gov

Survey on Drug Use of Micamlo Combination Tablets AP in Patients With Hypertension

Boehringer Ingelheim·observational·Posted May 13, 2011·Updated Aug 18, 2014

In Brief

An observational study evaluating Micamlo for Hypertension. Completed, enrolled 1,157 participants across 254 sites.

Detailed Summary

Investigation of safety and efficacy of daily use of Micamlo Combination Tablets AP in patients with Hypertension

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 13, 2011
Enrollment StartMay 1, 2011
Primary CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 15.1 years ago

Interventions

Micamlodrug

Telmisartan plus Amlodipine T40/A5